-
Biotech Most Volatile – CVM, Peregrine Pharmaceuticals (NASDAQ:PPHM), Geron Corporation (NASDAQ:GERN), Vical Incorporated (NASDAQ:VICL)
CEL-SCI Corporation (NYSEMKT:CVM) stock closed at $1.16, up $0.13 (or +12.62%), following the announcement that the company has received green light from the Medicines and Medical Device Agency of Serbia to begin enrollment of subjects in its Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine (Leukocyte Interleukin, Injection).…
-
Biotech Top Gainers – Geron Corporation (NASDAQ:GERN), Peregrine Pharmaceuticals (NASDAQ:PPHM), Zalicus Inc (NASDAQ:ZLCS), Questcor Pharmaceuticals Inc (NASDAQ:QCOR)
TheStreet Quant Ratings rates Geron Corporation (NASDAQ:GERN) as a sell. Shares of Geron Corporation (NASDAQ:GERN) is currently trading at $5.28. Currently share price of the company was traded in the range of $5.25 – $5.49. Company now has a market value of $682.24 billion. Geron Corporation (NASDAQ:GERN) price to sales ratio in past twelve months…
-
Biotech Top Gainers – MannKind Corporation (NASDAQ:MNKD), Sangamo Biosciences, Inc. (NASDAQ:SGMO), Sequenom, Inc. (NASDAQ:SQNM), Geron Corporation (NASDAQ:GERN)
MannKind Corporation (NASDAQ:MNKD) surged 9.22%, rising again seemingly on optimism that the company is targeting a large unmet need in the ever-expanding diabetes space and its main focus is on its wonder-drug: AFREZZA. Some may be hopeful that AFREZZA is going to become the dominant player in the $44B insulin market due to its unique…
-
Biotech Top Losers – Ariad Pharmaceuticals, (NASDAQ:ARIA), Coronado Biosciences (NASDAQ:CNDO), Geron Corporation (NASDAQ:GERN), XOMA (NASDAQ:XOMA)
Ariad Pharmaceuticals (NASDAQ:ARIA) was downgraded by research analysts at Thomson Reuters/Verus from a “hold” rating to a “sell” rating in a report released on Tuesday, Analyst Ratings Network reports. Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) closed at $6.64 during last trading session. The share price of the company yesterday traded in the range of $6.51…
-
Biotech Top Gainers – Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals (NYSEMKT: INO), Geron Corporation (NASDAQ:GERN), ACADIA Pharmaceuticals (NASDAQ:ACAD)
Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA continue to move higher on Monday morning following Friday’s decision by the U.S. Food and Drug Administration (FDA) to reinstate the company’s leukemia drug Iclusig to the market, albeit for a much smaller population of patients. Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) closed at $ 7.00 during last trading…
-
Biotech Startups Now Need A Very Good Kind Of Product To Get FDA Approval – (PPHM, GERN, ZLCS, ARNA)
New companies entering the U.S. biotechnology industry have been warned to get ready for a long, drawn-out process, after reports came in that the US Food and Drug Administration has become further conservative with its approvals. Frank Glatz, who is a managing director of Melbourne-based Company Cardia Bioplastics, said that new biotech companies should not…
-
Major Movements; Apple Inc (NASDAQ:AAPL) As One Of The Fantastic Three Record Price Breakers
U.S. stocks retreated from multiyear highs as weak trade data from China increased fears related to the growth rate in the world’s second-biggest economy and expectations high for the Federal Open Market Committee to indicate another series of bond-buying in the days ahead. Three key giants including Google Inc (NASDAQ:GOOG), Amazon.com, Inc. (NASDAQ:AMZN) and…